SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-010484
Filing Date
2018-05-03
Accepted
2018-05-03 07:01:40
Documents
57
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20180331.htm 10-Q 930916
2 EX-31.1 nerv-ex311_6.htm EX-31.1 16934
3 EX-31.2 nerv-ex312_8.htm EX-31.2 16736
4 EX-32.1 nerv-ex321_7.htm EX-32.1 9569
  Complete submission text file 0001564590-18-010484.txt   4510344

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nerv-20180331.xml EX-101.INS 865154
6 XBRL TAXONOMY EXTENSION SCHEMA nerv-20180331.xsd EX-101.SCH 44298
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20180331_cal.xml EX-101.CAL 34179
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20180331_def.xml EX-101.DEF 180986
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20180331_lab.xml EX-101.LAB 356465
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20180331_pre.xml EX-101.PRE 290605
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 18801749
SIC: 2834 Pharmaceutical Preparations